83 related articles for article (PubMed ID: 16686338)
21. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.
DeMartini W; Lehman C; Partridge S
Acad Radiol; 2008 Apr; 15(4):408-16. PubMed ID: 18342764
[TBL] [Abstract][Full Text] [Related]
22. Circulating tumor cells in breast cancer.
Ignatiadis M; Georgoulias V; Mavroudis D
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):55-60. PubMed ID: 18197007
[TBL] [Abstract][Full Text] [Related]
23. Resource use and cost of diagnostic workup of women with suspected breast cancer.
Lee DW; Stang PE; Goldberg GA; Haberman M
Breast J; 2009; 15(1):85-92. PubMed ID: 19120378
[TBL] [Abstract][Full Text] [Related]
24. Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery.
Shi Q; Harris LN; Lu X; Li X; Hwang J; Gentleman R; Iglehart JD; Miron A
J Proteome Res; 2006 Nov; 5(11):2947-55. PubMed ID: 17081046
[TBL] [Abstract][Full Text] [Related]
25. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
Shen C; Hu L; Xia L; Li Y
Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
[TBL] [Abstract][Full Text] [Related]
26. Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Lönneborg A; Aarøe J; Dumeaux V; Børresen-Dale AL
Expert Rev Anticancer Ther; 2009 Aug; 9(8):1115-23. PubMed ID: 19671031
[TBL] [Abstract][Full Text] [Related]
27. Breast cancer detection by Michaelis-Menten constants via linear programming.
Blokh D; Afrimzon E; Stambler I; Korech E; Shafran Y; Zurgil N; Deutsch M
Comput Methods Programs Biomed; 2007 Mar; 85(3):210-3. PubMed ID: 17188399
[TBL] [Abstract][Full Text] [Related]
28. Genesis Bioventures to acquire Biomedical Diagnostics.
Expert Rev Mol Diagn; 2001 Sep; 1(3):246. PubMed ID: 11901824
[No Abstract] [Full Text] [Related]
29. Proteomics: new technologies and clinical applications.
Latterich M; Abramovitz M; Leyland-Jones B
Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
[TBL] [Abstract][Full Text] [Related]
30. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
31. Knowledge and practice of breast cancer screening among Jordanian nurses.
Alkhasawneh IM
Oncol Nurs Forum; 2007 Nov; 34(6):1211-7. PubMed ID: 18024348
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
Mostert B; Sleijfer S; Foekens JA; Gratama JW
Cancer Treat Rev; 2009 Aug; 35(5):463-74. PubMed ID: 19410375
[TBL] [Abstract][Full Text] [Related]
33. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
34. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.
Riethdorf S; Fritsche H; Müller V; Rau T; Schindlbeck C; Rack B; Janni W; Coith C; Beck K; Jänicke F; Jackson S; Gornet T; Cristofanilli M; Pantel K
Clin Cancer Res; 2007 Feb; 13(3):920-8. PubMed ID: 17289886
[TBL] [Abstract][Full Text] [Related]
35. Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
Murph M; Tanaka T; Pang J; Felix E; Liu S; Trost R; Godwin AK; Newman R; Mills G
Methods Enzymol; 2007; 433():1-25. PubMed ID: 17954226
[TBL] [Abstract][Full Text] [Related]
36. Computerized analysis of tissue density effect on missed cancer detection in digital mammography.
Li L; Wu Z; Salem A; Chen Z; Chen L; George F; Kallergi M; Berman C
Comput Med Imaging Graph; 2006 Jul; 30(5):291-7. PubMed ID: 16837164
[TBL] [Abstract][Full Text] [Related]
37. Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
Sunami E; Vu AT; Nguyen SL; Giuliano AE; Hoon DS
Ann N Y Acad Sci; 2008 Aug; 1137():171-4. PubMed ID: 18837943
[TBL] [Abstract][Full Text] [Related]
38. Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer.
Salem AM; Zohny SF; Abd El-Wahab MM; Hamdy R
Clin Biochem; 2007 Nov; 40(16-17):1201-8. PubMed ID: 17889845
[TBL] [Abstract][Full Text] [Related]
39. A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display.
Pavoni E; Pucci A; Vaccaro P; Monteriù G; Ceratti Ade P; Lugini A; Virdis RA; Cortesi E; De Gaetano A; Panunzi S; Felici F; Minenkova O
Cancer Detect Prev; 2006; 30(3):248-56. PubMed ID: 16876336
[TBL] [Abstract][Full Text] [Related]
40. The prognostic implications of circulating tumor cells in patients with breast cancer.
Smerage JB; Hayes DF
Cancer Invest; 2008 Mar; 26(2):109-14. PubMed ID: 18259939
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
